Prevalence of drug interactions in elderly patients with multimorbidity in primary care

被引:0
作者
Susana Sánchez-Fidalgo
Maria Isabel Guzmán-Ramos
Mercedes Galván-Banqueri
Máximo Bernabeu-Wittel
Bernardo Santos-Ramos
机构
[1] University Hospital Valme,Pharmacy Service
[2] University Hospital Virgen del Rocio,Internal Medicine Service
来源
International Journal of Clinical Pharmacy | 2017年 / 39卷
关键词
Aged; Drug interaction; Outpatients; Patients with multimorbidity; Prevalence;
D O I
暂无
中图分类号
学科分类号
摘要
Background Drug interactions (DIs) are a significant cause of medication-related problems. The aging population, high chronic diseases prevalence and polypharmacy are closely associated factors. Aim of the review To study the prevalence, types and associated factors of DIs in multimorbidity patients of over 65 years of age in primary care. Methods Relevant studies on DI prevalence in this population were reviewed in PubMed, Cochrane Library and EMBASE (January 2000–December 2015). Independent variables (duration, target population, age, sex, mean of drugs and diseases, geographical localization, DI databases used and study designs) and dependent variables (prevalence, number of DIs per 100 patients and per patient, number of clinically-relevant DIs per 100 patients, most common DI and associated factors) were classified for each article. Results The search generated 749 articles and 46 duplicates were discarded. After reviewing, 10 articles were included. Seven studies were observational and 3 were quasi-experimental. Seven out of 10 used interaction databases. Only 2 studies described both actual and potential DIs. The prevalence of multimorbidity patients with DI ranged from 25.1 to 100% and the number of DIs per 100 patients was from 30 to 388.3. All the lower values correspond to the study conducted at the nursing home. This could be due to special care offered in these centres, where the medication is more controlled. The most frequent DIs were reported in five articles. However, these results could not be correlated since they were ranked using different methodologies. ACEIs, diuretics and NSAID were the most common therapeutic groups. Finally, 5 studies identified factors associated with the presence of potential DIs. The number of drugs and age were the most significant factors. Conclusions There is little evidence of prevalence of actual and potential DIs in elderly patients with multimorbidity in outpatient settings, showing widely heterogeneous results.
引用
收藏
页码:343 / 353
页数:10
相关论文
共 170 条
  • [11] Thorslund M(2008)Prevalence and predictors of potential drugdrug interactions in Regione EmiliaRomagna, Italy J Clin Pharm Ther 33 14151-383
  • [12] Boyd CM(2008)Drug drug interactions in a geriatric outpatient cohort: prevalence and relevance Drugs Aging 25 3435-924
  • [13] Darer J(2010)Drug drug interactions in multicentre polypathological polymedicated patients Rev Clin Esp 210 2708-795
  • [14] Boult C(2010)Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany Pharm World Sci 32 566-191
  • [15] Fried LP(2011)Frequency and determinants of potential drug drug interactions in an elderly population receiving regular home visits by Gps results of the home medication review in the AgnESstudies Pharmacoepidemiol Drug Saf 20 13118-497
  • [16] Boult L(2013)Actual drugdrug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study Eur J Clin Pharmacol 69 171724-1681
  • [17] Wu AW(2013)Hoffmann W Effects of a three party healthcare network on the incidence levels of drug related problems Int J Clin Pharm. 35 76371-141
  • [18] Opondo D(2016)Inappropriate medication use among underserved elderly African Americans J Aging Health. 28 118-146
  • [19] Eslami S(2004)Identification of serious drug–drug interactions: results of the partnership to prevent drug–drug interactions J Am Pharm Assoc. 44 142-1988
  • [20] Visscher S(1994)A summated score for theMedication Appropriateness Index: development and assessment of clinimetric properties including content validity J Clin Epidemiol 47 891-302